$EYEN
Eyenovia Inc Stock $eyen

$eyen Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000114420418044570 Filed on August 14, 2018

Income Statement

Concept	2018 Q3	2018 Q2	2017 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.830M	$910.0K	$220.0K
YoY Change	490.32%	313.64%
% of Gross Profit
Research & Development	$2.488M	$2.412M	$751.9K
YoY Change	336.09%	220.8%
% of Gross Profit
Depreciation & Amortization	$10.00K	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$4.320M	$3.321M	$976.9K
YoY Change	388.02%	239.96%
Operating Profit	-$4.320M	-$3.321M	-$976.9K
YoY Change	388.02%	239.96%
Interest Expense	-$964.00	$0.00	$0.00
YoY Change	-244.96%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.320M	-$3.320M	-$980.0K
YoY Change	390.91%	238.78%
Income Tax
% Of Pretax Income
Net Earnings	-$4.321M	-$3.319M	-$976.6K
YoY Change	388.5%	239.86%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$430.7K	-$332.0K	-$98.59K
COMMON SHARES
Basic Shares Outstanding	9.999M shares	9.937M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q3	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.04M	$24.56M
YoY Change	183.94%
Cash & Equivalents	$21.04M	$24.56M	$1.464M
Short-Term Investments
Other Short-Term Assets	$300.0K	$240.0K
YoY Change	130.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$21.34M	$24.81M
YoY Change	183.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.15K	$16.48K
YoY Change	-62.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$120.0K	$0.00
YoY Change	9.09%
Total Long-Term Assets	$129.0K	$16.48K
YoY Change	-14.03%
TOTAL ASSETS
Total Short-Term Assets	$21.34M	$24.81M
Total Long-Term Assets	$129.0K	$16.48K
Total Assets	$21.47M	$24.82M
YoY Change	179.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$840.2K	$723.0K
YoY Change	162.57%
Accrued Expenses	$840.0K	$490.0K
YoY Change	211.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.729M	$1.280M
YoY Change	193.09%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00
YoY Change	-100.0%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.729M	$1.280M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$1.732M	$1.280M
YoY Change	-75.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.33M	-$26.01M
YoY Change
Common Stock	$1.009K	$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.74M	$23.54M
YoY Change
Total Liabilities & Shareholders Equity	$21.47M	$24.82M
YoY Change	179.21%

Cashflow Statement

Concept	2018 Q3	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	-$4.321M	-$3.319M	-$976.6K
YoY Change	388.5%	239.86%
Depreciation, Depletion And Amortization	$10.00K	$0.00	$0.00
YoY Change
Cash From Operating Activities	-$3.580M	-$3.040M	-$1.040M
YoY Change	331.33%	192.31%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	60.00K	0.000	0.000
YoY Change	-99.11%
NET CHANGE
Cash From Operating Activities	-3.580M	-3.040M	-1.040M
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	60.00K	0.000	0.000
Net Change In Cash	-3.520M	-3.040M	-1.040M
YoY Change	-159.26%	192.31%
FREE CASH FLOW
Cash From Operating Activities	-$3.580M	-$3.040M	-$1.040M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$3.580M	-$3.040M	-$1.040M
YoY Change	326.19%	192.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Operating Expenses OperatingExpenses	6752714	USD
CY2018Q2	us-gaap	Prepaid Insurance PrepaidInsurance	221573	USD
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	384	USD
CY2018Q2	eyen	Prepaid Patent Expense PrepaidPatentExpense	21884	USD
CY2017Q4	eyen	Prepaid Patent Expense PrepaidPatentExpense	7833	USD
CY2018Q2	eyen	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	0	USD
CY2017Q4	eyen	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	28932	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	243457	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37149	USD
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1100000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27300000	USD
CY2018Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	175000	USD
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2211000	USD
CY2018Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	115049	USD
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6748670	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2082940	USD
	us-gaap	Malpractice Loss Contingency Insurance Recoveries MalpracticeLossContingencyInsuranceRecoveries	10000000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2412164	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	751930	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4506259	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1662771	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2246455	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	420900	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	908806	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	224949	USD
CY2018Q2	eyen	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	136068	USD
CY2017Q4	eyen	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	120455	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11483	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13148	USD
CY2018Q2	eyen	Credit Card Payable CreditCardPayable	58700	USD
CY2017Q4	eyen	Credit Card Payable CreditCardPayable	9843	USD
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	3320970	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	976879	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10234	USD
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2566530	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9998646	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8807864	shares
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	41831	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2083671	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3320970	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-976879	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000	shares
	us-gaap	Operating Expenses OperatingExpenses	2083671	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6752714	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2266667	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9998646	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2266667	shares
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000	shares
CY2018Q2	eyen	Accrued Legal Expenses Current AccruedLegalExpensesCurrent	19238	USD
CY2017Q4	eyen	Accrued Legal Expenses Current AccruedLegalExpensesCurrent	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	652088	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6390	USD
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q2	us-gaap	Accrued Rent Current AccruedRentCurrent	18000	USD
CY2017Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	0	USD
CY2018Q2	us-gaap	Cash Cash	24561711	USD
CY2017Q4	us-gaap	Cash Cash	5249511	USD
CY2018Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1907	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	288	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4044	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	731	USD
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2018Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	21823	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.92
CY2018Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	24500000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	206308	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15777	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	476622	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	228669	USD
CY2018Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	24311711	USD
CY2017Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4999511	USD
	dei	Entity Registrant Name EntityRegistrantName	EYENOVIA, INC.
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-3319063	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-976591	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	24805168	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	5286660	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16477	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27960	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1921959	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4807788	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001682639
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	383482	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-62762	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5431303	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1913272	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2018Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	USD
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	328700	USD
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.43
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
CY2018Q2	us-gaap	Assets Assets	24821645	USD
CY2017Q4	us-gaap	Assets Assets	5643320	USD
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2566530	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9998646	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	EYEN
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10234	USD
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9998646	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	723006	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	246384	USD
CY2018Q2	eyen	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	556745	USD
CY2017Q4	eyen	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	306263	USD
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000	shares
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25089000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	345497	USD
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	0	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1279751	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	552647	USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2730000	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24743503	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	19312200	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1923506	USD
CY2018Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5249511	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3387288	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	257	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24561711	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1463782	USD
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3087133	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49550750	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24351138	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26009856	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19261186	USD
CY2018Q1	eyen	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	24500000	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	464	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
	eyen	Payment Of Accrued Issuance Costs PaymentOfAccruedIssuanceCosts	-133000	USD
	eyen	Payment Of Accrued Issuance Costs PaymentOfAccruedIssuanceCosts	0	USD
CY2018Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	2800000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	23541894	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5090673	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24821645	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5643320	USD
CY2018Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	4702116	shares
	eyen	Reduction In Additional Paid In Capitalstock Issuance Costs ReductionInAdditionalPaidInCapitalstockIssuanceCosts	-195700	USD
	eyen	Reduction In Additional Paid In Capitalstock Issuance Costs ReductionInAdditionalPaidInCapitalstockIssuanceCosts	0	USD
CY2018Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2018Q2	eyen	Accrued Offering Costs AccruedOfferingCosts	0	USD
CY2017Q4	eyen	Accrued Offering Costs AccruedOfferingCosts	133000	USD
CY2017Q4	eyen	Minority Interest Ownership Percentage In Company MinorityInterestOwnershipPercentageInCompany	0.05	pure
CY2018Q1	eyen	Gross Proceeds Of Stock Value Issued During Period GrossProceedsOfStockValueIssuedDuringPeriod	27300000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.72
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.72
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0269	pure
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0269	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0283	pure
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0283	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.4	pure
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.4	pure
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1684416	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	175668	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1860084	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1116438	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.68
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.72
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.35
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.48
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7780706	USD
CY2018Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1860084	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3094	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	652088	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6390	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1512	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12866	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1134	USD
CY2018Q2	eyen	Accrued Expenses And Other Liabilities Currents AccruedExpensesAndOtherLiabilitiesCurrents	556745	USD
CY2017Q4	eyen	Accrued Expenses And Other Liabilities Currents AccruedExpensesAndOtherLiabilitiesCurrents	306263	USD
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5318423	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	1412700
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2018Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1116438	shares
CY2018Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-3.75
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P36M
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	175668	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.72

Files In Submission

Name	View Source	Status
0001144204-18-044570-index-headers.html	Edgar Link	pending
0001144204-18-044570-index.html	Edgar Link	pending
0001144204-18-044570.txt	Edgar Link	pending
0001144204-18-044570-xbrl.zip	Edgar Link	pending
eyen-20180630.xml	Edgar Link	completed
eyen-20180630.xsd	Edgar Link	pending
eyen-20180630_cal.xml	Edgar Link	unprocessable
eyen-20180630_def.xml	Edgar Link	unprocessable
eyen-20180630_lab.xml	Edgar Link	unprocessable
eyen-20180630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv500003_10q.htm	Edgar Link	pending
tv500003_ex31-1.htm	Edgar Link	pending
tv500003_ex31-2.htm	Edgar Link	pending
tv500003_ex32-1.htm	Edgar Link	pending
tv500003_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EYEN
Eyenovia Inc Stock $eyen

2018 Q3 Form 10-Q Financial Statement

#000114420418044570 Filed on August 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EYEN Eyenovia Inc Stock $eyen

2018 Q3 Form 10-Q Financial Statement

#000114420418044570 Filed on August 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EYEN
Eyenovia Inc Stock $eyen